Guidance

Influenza vaccine: ovalbumin content

Data on the ovalbumin content of the influenza vaccines for the 2021 to 2022 flu season.

From:
Public Health England
Published
29 July 2016
Last updated
23 June 2021 — See all updates

This publication was withdrawn on

This guidance was for the 2021 to 2022 flu season. Please see the latest list of vaccines marketed in the UK.

Documents

[Withdrawn] Influenza vaccines: 2021 to 2022 flu season

HTML

[Withdrawn] Influenza vaccines: 2021 to 2022 flu season (print version)

Ref: PHE publications gateway number 2021199

PDF, 739 KB, 1 page

Details

This table lists all of the ovalbumin content of the influenza vaccines that are marketed in the UK for the 2021 to 2022 flu vaccination season.

For information on the use of influenza vaccines in egg allergic individuals please see the green book influenza chapter.

Updates to this page

Published 29 July 2016
Last updated 23 June 2021 + show all updates

  1. Updated Quadrivalent Influvac® sub-unit Tetra to suitable for children from 6 months of age.

  2. Updated ovalbumin content for the 2021 to 2022 flu season.

  3. Ovalbumin content list updated.

  4. Added table for the 2020 to 2021 flu season.

  5. Updated title of document to 'Influenza vaccines: 2019 to 2020 flu season.'

  6. Updated with the vaccines for the 2018 to 2019 flu season.

  7. Added a note to the table about an approved batch of Vaxigrip Tetra and updated the age indication for Mylan’s quadrivalent influenza vaccine products to 3 years and over, instead of from 18.

  8. Added this season's Ovalbumin influenza vaccine table.

  9. Added Ovalbumin content of the influenza vaccines for 2017 to 2018 flu season.

  10. First published.

Sign up for emails or print this page

Related content